- RecruitingPHASE1, PHASE2
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
This study is for people with advanced breast cancer that has grown despite previous treatments. It tests a new combination of targeted radiation therapy and chemotherapy to see if it can stop cancer growth and if it's safe. We're looking at different doses to find the best way to use these treatments.
For: Breast CancerUnited States · Australia · Canada - Active not recruitingPHASE1
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
This study looks at new ways to treat prostate cancer that has spread. It uses special scans to find cancer cells and then delivers targeted radiation therapy to those cells, aiming to see how well it works and if it's safe.
For: Metastatic Neuroendocrine Prostate CancerUnited States · France · Germany